Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO5459072 in Celiac Disease
NCT02679014Phase 1Completed
- Sponsor
- Roche
- Start
- Mar 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in celiac disease comparing RO5459072 with Placebo (2 arms). Primary endpoint: Overall Numbers of Participants who are Responders to the Gluten Challenge at Day 29. Started Mar 2016; status: completed.
02
Drugs
petesicatib
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT02679014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02679014.